Rocket Pharmaceuticals Q2 EPS USD 1.08
RCKT•Quarterly net income
Aug. 10 (Reuters) - Rocket Pharmaceuticals Q2 net income USD 123.2 million.
Related News
BRT Apartments Q2 FY26 net loss widens to $3.22 million; revenue rises 1.1% to $24.47 million
BRT•
ADM prices USD 1 billion bond offering
ADM•
Strait talking
SPY•
Babcock & Wilcox publishes investor presentation on AI data center power solutions, coal and gas generation pipeline
BW•
Mesa Laboratories FY27 Q1 operating income more than doubled to $7.03 million; revenue rises 1% to $60.14 million
MLAB•